Polymyxin B-immobilized fibre haemoperfusion reduces urinary 8-hydroxy-2′-deoxyguanosine levels in patients with septic shock

References

• Salvemini D, Cuzzocrea S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 2002;33:1173–85.
   PubMed Web of Science ®Google Scholar
• Alonso de Vega JM, Diaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflam-matory response syndrome. Crit Care Med 2002;30:1782–6.
   PubMed Web of Science ®Google Scholar
• Sanikidze TV, Tkhilava NG, Papaya MB, Datunashvili IV, Gongadze MT, Gamrekelashvili DD, Bakhutashvili VI. Role of free nitrogen and oxygen radicals in the pathogenesis of lipopolysaccharide-induced endotoxemia. Bull Exp Biol Med 2006;141:211–5.
   Google Scholar
• Kolls JK. Oxidative stress in sepsis: a redox redux. J Chin Invest 2006;116:860–3.
   PubMed Web of Science ®Google Scholar
• Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-0HdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetes. Chin Chim Acta 2004;339:1–9.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, Matsuo T, Kukidome D, Wake N, Matsumura T, Miyamura N, et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complica-tions in type 2 diabetes. Diabetes Care 2003;26:1507–12.
   PubMed Web of Science ®Google Scholar
• Kimura S, Yamauchi H, Hibino Y, Iwamoto M, Sera K, Ogino K. Evaluation of urinary 8-hydroxydeoxyguanine in healthy Japanese people. Basic Chin Pharmacol Toxicol 2006; 98:496–502.
   PubMed Web of Science ®Google Scholar
• Endo K, Miyashita Y, Sasaki H, Ebisuno M, Ohira M, Saiki A, Koide N, Oyama T, Takeyoshi M, Shirai K. Probucol and atorvastatin decreased urinary 8-hydroxy- 2'-deoxyguanosine in patients with diabetes and hypercholesterolemia. J Ather-oscler Thromb 2006;13:68–75.
   PubMed Web of Science ®Google Scholar
• Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003;7:108–14.
   PubMed Web of Science ®Google Scholar
• Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amano I, et al. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001;25:660–8.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis sec-ondary to intra-abdominal infection. Shock 2005;23:400–5.
   Google Scholar
• Nakamura T, Matsuda T, Suzuki Y, Shoji H, Koide H. Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis. Dial Transplant 2003;32:602–7.
   Google Scholar
• Nakamura T, Kawagoe Y, Suzuki T, Shoji H, Ueda Y, Kobayashi N, Koide H. Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock. Blood Purif 2005;23: 417–20.
   Google Scholar
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–74.
   Google Scholar
• Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine. Intens Care Med 1996;22:707–10.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–29.
   PubMed Web of Science ®Google Scholar
• Igishi T, Hitsuda Y, Kato K, Sako T, Burioka N, Yasuda K, Sano H, Shigeoka Y, Nakanishi H, Shimizu E. Elevatedurinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease. Respirology 2003;8: 455–60.
   PubMed Web of Science ®Google Scholar
• Sato S, Mizuno Y, Hattiori N. Urinary 8-hydroxydeoxygua-nosine levels as a biomarker for progression of Parkinson disease. Neurology 2005;64: 1081–3.
   Google Scholar
• Hata I, Kaji M, Hirano S, Shigematsu Y, Tsukahara H, Mayumi M. Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr Int 2006;48:58–61.
   PubMed Web of Science ®Google Scholar
• Kanaya S, Ikeya M, Yamamoto K, Moriya T, Furuhashi K, Sonoda M, Goto K, Ochi H. Comparison of an oxidative stress biomarker "urinary 8-hydroxy-2'- deoxyguanosine" between smokers and non-smokers. Biofactors 2004;22: 255–8.
   PubMed Web of Science ®Google Scholar
• Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmon-ary oxygenation. Crit Care 2005;9:653–61.
   PubMed Web of Science ®Google Scholar
• Kohro S, Imaizumi H, Yamakage M, Matsuda Y, Namiki A, Asai Y, Maruyama I. Anandamide adsorption by direct hemoperfusion with polymyxin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J Anesth 2006;20:11–6.
   Google Scholar
• Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T. Quantitative immuno-histochemical determination of 8-hydroxy-2'- deoxyguano-sine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997;76: 365–74.
   Google Scholar
• Saito S, Yamauchi H, Hasui Y, Kurashige J, Ochi H, Yoshida K. Quantitative determination of urinary 8-hydroxydeoxy-guanosine (8-0H-dG) by using ELISA. Res Commun Mol Pathol Pharmacol 2000;107:39–44.
   PubMed Web of Science ®Google Scholar
• Mishra V, Baines M, Wenstone R, Shenkin A. Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Chin Biochem 2005;42:269–76.
   PubMed Web of Science ®Google Scholar
• Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Ki-noshita Y, Ogawa H. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003;31:1048–52.
   Google Scholar
• Maeshima E, Liang XM, Goda M, Otani H, Mune M. The efficacy of vitamin E against oxidative damage and autoanti-body production in systemic lupus erythematosus: a pre-liminary study. Chin Rheumatol 2007;26: 401–4.
   Google Scholar
• Tsukahara M. Biomarkers for oxidative stress: clinical appli-cation in pediatric medicine. Curr Med Chem 2007;14:339–51.
   PubMed Web of Science ®Google Scholar
• Vincent JL. Organ dysfunction in patients with severe sepsis. Surg Infect (Larchmt) 2006;7\(Suppl. 2):S69–72.
   Google Scholar
• Mishra DP, Dhali A. Endotoxin induces luteal cell apoptosis through the mitochondrial pathway. Prostagl Other Lipid Mediat 2007;83:79–88.
   Google Scholar
• Li L, Shoji W, Takano H, Nishimura N, Aoki Y, Takahashi R, Goto S, Kaifu T, Takai T, Obinata M. Increased susceptibility of MER5 knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun 2007;35:715–21.
   Google Scholar
• Sakaguchi S, Furusawa S. Oxidative stress and septic shock metabolic aspects of oxygen-derived free radicals generation in the liver during endotoxemia. FEMS Immunol Med Microbiol 2006;47:167–77.
   PubMed Web of Science ®Google Scholar
• Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro LJ, Napoli C. The role of oxidative stress in adult critical care. Free Radical Biol Med 2006;40:398–406.
   PubMed Web of Science ®Google Scholar
• Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antiox-idant nutrients: a systemic review of trace elements and vitamins in the critically ill patients. Intens Care Med 2005; 31:327–37.
   PubMed Web of Science ®Google Scholar
• Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002;236:814–22.
   Google Scholar
• Abiles J, de la Cruz AP, Castano J, Rodriguez-Eluira M, Aguayo E, Moreno-Torres R, Liopis J, Aranda P, Arguelles S, Ayala A, et al. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, indepen-dent severity: a cohort study. Crit Care 2006;10:R146.
   Google Scholar
• Naka T, Shinozaki M, Okizawa T, Shima Y, Takaesu H, Nasu H. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock. Ther Apher Dial 2006;10:7–11.
   PubMed Web of Science ®Google Scholar